Clinical Trials Directory

Trials / Completed

CompletedNCT01073592

Comparison Between Foresee Home and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)

Comparison Between Home Macular Perimeter (FORESEE HOME) and OCT Visual Field Defects in Patients With CNV

Status
Completed
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
Notal Vision Ltd. · Industry
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

The Foresee Home is used in the recent years to detect age-related macular degeneration (AMD) lesions. The device is capable of differentiation as to stages of AMD and early detection of changes including choroidal neovascularization (CNV). The Foresee Home demonstrates a high level of sensitivity and specificity as to the different stages of AMD including newly diagnosed or early detection of CNV. The OCT may be use as well to identify choroidal neovascularization (CNV). Comparison between the two methods will allow better understanding of both devices. The Foresee Home can use as an assessment tool for the progression and success of the treatment given to AMD lesions. Therefore, evaluation the size and the location of the treated lesions may serve as an additional tool.

Conditions

Timeline

Start date
2009-08-01
Primary completion
2013-01-01
Completion
2013-03-01
First posted
2010-02-23
Last updated
2013-05-17

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01073592. Inclusion in this directory is not an endorsement.